Smoking reduction: What can interventions achieve and how should they be designed?;Reduziertes Rauchen: Was können Interventionen erreichen und wie sollten sie gestaltet sein?

Suchttherapie

Volumn 15, Issue 4, 2014, Pages 179-186

  Ruther T ^a   Eberhardt, K ^a   Kiss, A ^a   Pogarell, O ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

cigarette reduction; harm reduction; reducing cigarettes; reducing smoking; reduction of cigarettes

Indexed keywords

EID: 84910113095     PISSN: 14399903     EISSN: 1439989X     Source Type: Journal    
DOI: 10.1055/s-0034-1390490     Document Type: Review

References (50)

1. Lim S. S., Vos T., Flaxman A. D. et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet: 2012; 380 2224 2260
2. Doll R., Peto R., Boreham J. et al. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ (Clinical research ed): 2004; 328 1519
3. Klesges R. C., Sherrill-Mittleman D., Ebbert J. O. et al. Tobacco use harm reduction, elimination, and escalation in a large military cohort. Am J Public Health: 2010; 100 2487 2492
4. Glasgow R. E., Gaglio B., France E. K. et al. Do behavioral smoking reduction approaches reach more or different smokers? Two studies; similar answers. Addict Behav: 2006; 31 509 518
5. Pisinger C., Godtfredsen N. S. Is there a health benefit of reduced tobacco consumption? A systematic review. Nicotine Tob Res: 2007; 9 631 646
6. Hughes J. R., Carpenter M. J. Does smoking reduction increase future cessation and decrease disease risk? A qualitative review. Nicotine Tob Res: 2006; 8 739 749
7. Shiffman S., Hughes J. R., Ferguson S. G. et al. Smokers' interest in using nicotine replacement to aid smoking reduction. Nicotine Tob Res: 2007; 9 1177 1182
8. Bolliger C. T., Zellweger J. P., Danielsson T. et al. Influence of long-term smoking reduction on health risk markers and quality of life. Nicotine Tob Res: 2002; 4 433 439
9. Stellman S. D., Garfinkel L. Lung cancer risk is proportional to cigarette tar yield: evidence from a prospective study. Prev Medicine: 1989; 18 518 525
10. Keil U., Liese A. D., Hense H. W. et al. Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984-1992. Monitoring Trends and Determinants in Cardiovascular Diseases. Eur Heart J: 1998; 19 1197 1207
11. Meisinger C., Doring A., Thorand B. et al. Association of cigarette smoking and tar and nicotine intake with development of type 2 diabetes mellitus in men and women from the general population: the MONICA/KORA Augsburg Cohort Study. Diabetologia: 2006; 49 1770 1776
12. Teo K. K., Ounpuu S., Hawken S. et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet: 2006; 368 647 658
13. Bjartveit K., Tverdal A. Health consequences of smoking 1-4 cigarettes per day. Tob Control: 2005; 14 315 320
14. Tverdal A., Bjartveit K. Health consequences of reduced daily cigarette consumption. Tob Control: 2006; 15 472 480
15. Flanders W. D., Lally C. A., Zhu B. P. et al. Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption: results from Cancer Prevention Study II. Cancer Res: 2003; 63 6556 6562
16. Hughes J. R., Carpenter M. J. The feasibility of smoking reduction: an update. Addiction (Abingdon, England): 2005; 100 1074 1089
17. Godtfredsen N. S., Prescott E., Vestbo J. et al. Smoking reduction and biomarkers in two longitudinal studies. Addiction (Abingdon, England): 2006; 101 1516 1522
18. Gerber Y., Myers V., Goldbourt U. Smoking reduction at midlife and lifetime mortality risk in men: a prospective cohort study. Am J Epidemiol: 2012; 175 1006 1012
19. Hart C., Gruer L., Bauld L. Does smoking reduction in midlife reduce mortality risk? Results of 2 long-term prospective cohort studies of men and women in Scotland. Am J Epidemiol: 2013; 178 770 779
20. Lee P. N. The effect of reducing the number of cigarettes smoked on risk of lung cancer, COPD, cardiovascular disease and FEV(1) - a review. Regul Toxicol Pharmacol: 2013; 67 372 381
21. Gelkopf M., Noam S., Rudinski D. et al. Nonmedication smoking reduction program for inpatients with chronic schizophrenia: a randomized control design study. J Nerv Ment Dis: 2012; 200 142 146
22. Bernard P. P., Esseul E. C., Raymond L. et al. Counseling and exercise intervention for smoking reduction in patients with schizophrenia: a feasibility study. Arch Psychiatr Nurs: 2013; 27 23 31
23. Wu B. J., Chen H. K., Lee S. M. Do atypical antipsychotics really enhance smoking reduction more than typical ones?: the effects of antipsychotics on smoking reduction in patients with schizophrenia. J Clin Psychopharmacology: 2013; 33 319 328
24. Rohde P., Lewinsohn P. M., Brown R. A. et al. Psychiatric disorders, familial factors and cigarette smoking: I. Associations with smoking initiation. Nicotine Tob Res: 2003; 5 85 98
25. Olincy A., Young D. A., Freedman R. Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biol Psychiatry: 1997; 42 1 5
26. Ruther T., Bobes J., De Hert M. et al. EPA guidance on tobacco dependence and strategies for smoking cessation in people with mental illness. Eur Psychiatry: 2014; 29 65 82
27. Lindson-Hawley N., Aveyard P., Hughes J. R. Reduction versus abrupt cessation in smokers who want to quit. Cochrane Database Syst Rev: 2012; 11 CD008033
28. Okuyemi K. S., Thomas J. L., Warren J. et al. Relationship between smoking reduction and cessation among light smokers. Nicotine Tob Res: 2010; 12 1005 1010
29. Cropsey K. L., Jackson D. O., Hale G. J. et al. Impact of self-initiated pre-quit smoking reduction on cessation rates: results of a clinical trial of smoking cessation among female prisoners. Addict Behav: 2011; 36 73 78
30. Shiffman S., Ferguson S. G., Strahs K. R. Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. Am J Prev Med: 2009; 36 96 104 e101
31. Stead L. F., Lancaster T. Interventions to reduce harm from continued tobacco use. Cochrane Database Syst Rev: 2007; 10.1002/14651858.CD005231.pub2: CD005231
32. Asfar T., Ebbert J. O., Klesges R. C. et al. Do smoking reduction interventions promote cessation in smokers not ready to quit? Addict Behav: 2011; 36 764 768
33. Beard E., McNeill A., Aveyard P. et al. Association between use of nicotine replacement therapy for harm reduction and smoking cessation: a prospective study of English smokers. Tobacco Control: 2013; 22 118 122
34. Piper M. E., McCarthy D. E., Baker T. B. Assessing tobacco dependence: a guide to measure evaluation and selection. Nicotine Tob Res: 2006; 8 339 351
35. Mooney M. E., Johnson E. O., Breslau N. et al. Cigarette smoking reduction and changes in nicotine dependence. Nicotine Tob Res: 2011; 13 426 430
36. Beard E., Aveyard P., Brown J. et al. Assessing the association between the use of NRT for smoking reduction and attempts to quit smoking using propensity score matching. Drug Alcohol Depend: 2012; 126 354 361
37. Beard E., Aveyard P., McNeill A. et al. Mediation analysis of the association between use of NRT for smoking reduction and attempts to stop smoking. Psychol Health: 2012; 27 1118 1133
38. Peters E. N., Hughes J. R. The day-to-day process of stopping or reducing smoking: a prospective study of self-changers. Nicotine Tob Res: 2009; 11 1083 1092
39. Beard E., Vangeli E., Michie S. et al. The use of nicotine replacement therapy for smoking reduction and temporary abstinence: an interview study. Nicotine Tob Res: 2012; 14 849 856
40. Estabrooks P. A., Gaglio B., Morse E. F. et al. Defining and understanding success at smoking reduction: a mixed-methods study. Addic Beh: 2010; 35 1113 1119
41. Glasgow R. E., Gaglio B., Estabrooks P. A. et al. Long-term results of a smoking reduction program. Med Care: 2009; 47 115 120
42. Chan S. S., Leung D. Y., Abdullah A. S. et al. A randomized controlled trial of a smoking reduction plus nicotine replacement therapy intervention for smokers not willing to quit smoking. Addiction (Abingdon, England): 2011; 106 1155 1163
43. Lam T. H., Chan S. S., Abdullah A. S. et al. Smoking reduction intervention for smokers not willing to quit smoking: a randomised controlled trial. Hong Kong Med J: 2012; 18 03 4 8
44. Tang Y. Y., Tang R., Posner M. I. Brief meditation training induces smoking reduction. Proc Natl Acad Sci USA: 2013; 110 13971 13975
45. Moore D., Aveyard P., Connock M. et al. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ (Clinical research ed): 2009; 338 b1024
46. Beard E., McNeill A., Aveyard P. et al. Use of nicotine replacement therapy for smoking reduction and during enforced temporary abstinence: a national survey of English smokers. Addiction (Abingdon, England): 2011; 106 197 204
47. Beard E., Bruguera C., Brown J. et al. Was the expansion of the marketing license for nicotine replacement therapy in the United kingdom to include smoking reduction associated with changes in use and incidence of quit attempts? Nicotine Tob Res: 2013; 15 1777 1781
48. Hughes J. R., Rennard S. I., Fingar J. R. et al. Efficacy of varenicline to prompt quit attempts in smokers not currently trying to quit: a randomized placebo-controlled trial. Nicotine Tob Res: 2011; 13 955 964
49. Hatsukami D. K., Rennard S., Patel M. K. et al. Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking. Am J Med: 2004; 116 151 157
50. Franklin T. R., Harper D., Kampman K. et al. The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study. Drug Alcohol Depend: 2009; 103 30 36